Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2008-10-24
pubmed:abstractText
Recent reports suggest dyslipidemia impairs dendritic cell (DC) function and adaptive immunity. This study aimed to characterize the effect of hypercholesterolemia on antigen-presenting cell function of DCs and DC-dependent CD4(+) T-cell responses. DCs incubated in vitro with acetylated low-density lipoprotein cholesterol with or without an acyl-coenzyme A:cholesterol acyl-transferase inhibitor maintained their ability to prime CD4(+) T cells. Analysis of T-cell proliferation and interferon-gamma and tumor necrosis factor-alpha production after ex vivo coculture of naïve CD4(+) T cells with splenic, inguinal, or iliac DCs from low-density lipoprotein receptor-deficient (LDLR(-/-)) or apolipoprotein E-deficient (ApoE(-/-)) mice fed an atherogenic diet highlighted DC efficacy in effector T-cell generation under hypercholesterolemic conditions. Adoptive transfer of carboxyfluorescein diacetate, succinimidyl ester (CFSE)-labeled naïve CD4(+) T cells in LDLR(-/-) recipients and subsequent immunization demonstrated effective priming of naïve T cells in hypercholesterolemic mice. CFSE dilution analyses revealed that hypercholesterolemic DCs were equipotent in naïve CD4(+) T-cell priming efficacy with normocholesterolemic DCs. Quantitative real-time PCR and flow cytometric analyses demonstrated that DC expression of multiple molecules involved in antigen processing, presentation, and T-cell stimulation remained unaltered by dyslipidemia. Finally, endogenous antigen-primed CD4(+) T cells responded equivalently to a secondary ex vivo antigenic challenge, regardless of whether they were primed in vivo under hypercholesterolemic or control conditions, demonstrating that all essential steps in CD4(+) T-cell responses remain intact under atherogenic conditions. This study affirms that the adaptive immune response prevails under the hypercholesterolemic conditions present in atherosclerosis. In particular, DCs remain functional antigen-presenting cells and maintain their ability to prime CD4(+) T cells even when cholesterol-loaded.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-10191292, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-10330380, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-10446074, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-11113040, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-11207293, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-11457878, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-11509172, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-11913066, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-12426210, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-12615659, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-12732389, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-12871634, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-12907943, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-12923293, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-14568988, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-15096453, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-15233723, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-15280540, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-15306181, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-15485633, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-15662027, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-15665085, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-15771591, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-15855191, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-15983262, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-16369557, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-16428241, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-16461845, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-16778830, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-16894012, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-16973967, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-17158354, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-17296788, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-17898760, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-18079406, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-1911708, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-8696940, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-9199434, http://linkedlifedata.com/resource/pubmed/commentcorrection/18832748-9244201
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1524-4571
pubmed:author
pubmed:issnType
Electronic
pubmed:day
24
pubmed:volume
103
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
965-73
pubmed:dateRevised
2011-9-26
pubmed:meshHeading
More...